Dyskeratosis congenita
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Dyskeratosis congenita (DC) was originally defined as a rare inherited bone marrow failure (BMF) syndrome associated with distinct mucocutaneous features. Today DC is defined by its pathogenetic mechanism and mutations in components of the telomere maintenance machinery resulting in excessively short telomeres in highly proliferating tissues. With this new definition the disease spectrum has broadened and ranges from intrauterine growth retardation, cerebellar hypoplasia, and death in early childhood to asymptomatic mutation carriers whose descendants are predisposed to malignancy, BMF, or pulmonary disease. The degree of telomere dysfunction is the major determinant of disease onset and manifestations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“This gene encodes a protein, TIN2, that is not in the telomerase complex but is a component of the protein complex, shelterin, which binds to telomere DNA repeats, protecting them from degradation and from DNA repair enzymes [9].”
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Morin, G. B. (1989) · Cell · doi:10.1016/0092-8674(89)90035-4 · Cited by 1,495 · cited 1×
“In humans telomerase-based telomere elongation is the major mechanism that counteracts the process of continuous telomere shortening [10,11].”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 1×
“In some family members these mutations caused only isolated clinical features, such as BMF [31], PF [38,39], liver cirrhosis [40], osteoporosis [41] or MDS [42] (variable expressivity).”
BackgroundEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 1×
“Initially anticipation was described in telomerase null mice who only develop a disease phenotype after several rounds of inbreeding, and experiments in mice have elegantly shown that this is due to the inheritance of subsequently shorter telomeres with each round of inbreeding [58,59].”
BackgroundGreider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150 · cited 1×
“In humans telomerase-based telomere elongation is the major mechanism that counteracts the process of continuous telomere shortening [10,11].”
BackgroundHeiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976 · cited 1×
“The understanding that DC is caused by defects in telomere maintenance came with the positional cloning of the gene responsible for the X-linked form of the disease, DKC1, encoding the protein dyskerin [27], and the subsequent demonstration that dyskerin is an essential component of the telomerase complex necessary fo…”
BackgroundSelf-citationThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 10×
“TERC RNA levels and presumably the enzymatic activity of telomerase are not altered in patients with TINF2 mutations [37].”
BackgroundInfluentialSelf-citation
Cited by
Epidemiologic Trends in Head and Neck Cancer and Aids in Diagnosis
Vigneswaran, N., & Williams, M. D. (2014) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2014.01.001 · Cited by 815
Finding the end: recruitment of telomerase to telomeres
Nandakumar, J., & Cech, T. R. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3505 · Cited by 378
Dokal, I. (2011) · Hematology · doi:10.1182/asheducation-2011.1.480 · Cited by 266
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita
Zhong, F., Savage, S. A., Shkreli, M., Giri, N., Jessop, L., Myers, T., Chen, R., Alter, B. P., & Artandi, S. E. (2011) · Genes & Development · doi:10.1101/gad.2006411 · Cited by 262
Batista, L. F. Z., Pech, M. F., Zhong, F. L., Nguyen, H. N., Xie, K. T., Zaug, A. J., Crary, S. M., Choi, J., Sebastiano, V., Cherry, A., et al. (2011) · Nature · doi:10.1038/nature10084 · Cited by 260
Metadata
- Authors
- Bessler, M., Wilson, D. B., & Mason, P. J.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2010-05-21
- Volume
- 584
- Issue
- 17
- Pages
- 3831-3838
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W4241761291
- Cited by
- 81
- References
- 32
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dyskeratosis congenita. https://app.cochat.ai/papers/10.1016/j.febslet.2010.05.019
- The paper
- Bessler, M., Wilson, D. B., & Mason, P. J. (2010). Dyskeratosis congenita. FEBS Letters. https://doi.org/10.1016/j.febslet.2010.05.019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.